Literature DB >> 9440192

The soft keratoprosthesis.

D R Caldwell1.   

Abstract

PURPOSE: The purpose of this work was to develop a keratoprosthesis which utilizes a biocolonizable skirt attached to a soft, elastomeric optic for world-wide application.
METHODS: Over a period of 20 years, using in vivo animal implantation studies, a series of experiments was conducted testing materials for biocompatibility and durability which resulted in the development of an improved design. A new surgical technique was developed, using porous, biocolonizable haptics embedded within the sclera and combined with the established techniques of resection of Descemet's membrane and a conjunctival flap.
RESULTS: Animal implantation studies indicated that 6 haptics, equidistantly placed, was the optimal shape. Two clinical trials resulted in the selection of an aliphatic polyether-based urethane for the optic and 60 mu pore polytetrafluoroethylene for the porous ingrowth material. Heated, pressurized injection moulding proved to be the optimal bonding method between the skirt and the optic. Sclerally embedded haptics achieved excellent integration with the tissue.
CONCLUSIONS: This keratoprosthesis is a significant improvement over previous models with a rigid optic in that: 1. The porous ingrowth haptic is sclerally anchored, preventing extrusion. 2. It has a soft elastomeric optic which more successfully defuses the shearing forces of the keratoprosthesis/tissue interface secondary to blinking. 3. The optic is less massive and of greater circumference at the optic/tissue interface, thereby imparting less energy per area with a given movement. 4. The optic does not project posteriorly thereby decreasing anterior chamber irritation and reducing the possibility of glaucoma, uveitis, endophthalmitis, and retinal detachment. 5. This keratoprosthesis allows a normal field of view for the patient and an effective funduscopic view for the surgeon. 6. The large optical diameter eliminates problems with decentralization of the image. 7. It has a significantly better cosmetic appearance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440192      PMCID: PMC1298380     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  84 in total

1.  A new fluorocarbon for keratoprosthesis.

Authors:  J M Legeais; C Rossi; G Renard; M Salvoldelli; F D'Hermies; Y J Pouliquen
Journal:  Cornea       Date:  1992-11       Impact factor: 2.651

2.  IMPORTANCE OF POROSITY IN ARTERIAL PROSTHESES.

Authors:  W J FRY; M S DEWEESE; R O KRAFT; C B ERNST
Journal:  Arch Surg       Date:  1964-05

3.  Biomaterial-centered infection: microbial adhesion versus tissue integration.

Authors:  A G Gristina
Journal:  Science       Date:  1987-09-25       Impact factor: 47.728

4.  Prosthokeratoplasty.

Authors:  C H Dohlman; H A Schneider; M G Doane
Journal:  Am J Ophthalmol       Date:  1974-05       Impact factor: 5.258

5.  Porous methyl methacrylate as an implant material.

Authors:  D F Taylor; F B Smith
Journal:  J Biomed Mater Res       Date:  1972

6.  Ceramic keratoprostheses.

Authors:  F M Polack; G Heimke
Journal:  Ophthalmology       Date:  1980-07       Impact factor: 12.079

7.  A new alloplastic material for ophthalmic surgery.

Authors:  D W Lamberts; S C Grandon
Journal:  Ophthalmic Surg       Date:  1978-12

8.  Epithelialization of the anterior chamber. A complication of prosthokeratoplasty.

Authors:  A P Ferry; B L Gordon
Journal:  Arch Ophthalmol       Date:  1974-04

9.  Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses.

Authors:  A W Clowes; T R Kirkman; M A Reidy
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

View more
  8 in total

Review 1.  Development of hydrogel-based keratoprostheses: a materials perspective.

Authors:  David Myung; Pierre-Emile Duhamel; Jennifer R Cochran; Jaan Noolandi; Christopher N Ta; Curtis W Frank
Journal:  Biotechnol Prog       Date:  2008-04-19

2.  In vivo evaluation of titanium oxide and hydroxyapatite as an artificial cornea skirt.

Authors:  Xiao Wei Tan; Roger W Beuerman; Zhi Long Shi; Koon Gee Neoh; Donald Tan; Khiam Aik Khor; Jodhbir S Mehta
Journal:  J Mater Sci Mater Med       Date:  2012-03-17       Impact factor: 3.896

3.  Long-term follow-up of a supradescemetic keratoprosthesis in rabbits: an immunofluorescence study.

Authors:  Edgar M Espana; Ana C Acosta; Josef Stoiber; Viviana Fernandez; Peggy D Lamar; Franck L Villain; Emmanuel Lacombe; Eduardo Alfonso; Jean-Marie Parel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-03       Impact factor: 3.117

4.  Biocompatibility of poly(ethylene glycol) and poly(acrylic acid) interpenetrating network hydrogel by intrastromal implantation in rabbit cornea.

Authors:  Luo Luo Zheng; Vijay Vanchinathan; Roopa Dalal; Jaan Noolandi; Dale J Waters; Laura Hartmann; Jennifer R Cochran; Curtis W Frank; Charles Q Yu; Christopher N Ta
Journal:  J Biomed Mater Res A       Date:  2015-03-27       Impact factor: 4.396

Review 5.  [Treatment of vascularized high-risk eyes with a Boston keratoprosthesis].

Authors:  F Schaub; M Matthaei; P Enders; S Siebelmann; D Hos; B O Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2021-03-17       Impact factor: 1.059

Review 6.  Keratoprostheses for corneal blindness: a review of contemporary devices.

Authors:  Venkata S Avadhanam; Helen E Smith; Christopher Liu
Journal:  Clin Ophthalmol       Date:  2015-04-16

Review 7.  Histopathologic Evaluation of Polymer Supports for Pintucci-type Keratoprostheses: An Animal Study.

Authors:  Saeed Rahmani; Mozhgan Rezaei Kanavi; Mohammad Ali Javadi; Masoumeh Meskinfam Langroudi; Sasha Afsar Aski
Journal:  J Ophthalmic Vis Res       Date:  2019-07-18

8.  Biomimetic bone-like composites as osteo-odonto-keratoprosthesis skirt substitutes.

Authors:  Venkata Avadhanam; Ganesh Ingavle; Yishan Zheng; Sandeep Kumar; Christopher Liu; Susan Sandeman
Journal:  J Biomater Appl       Date:  2020-11-11       Impact factor: 2.646

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.